Royalty Pharma plcRPRXNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, modest growth trend.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$858.98M
↓ 12% below average
Average (9y)
$971.50M
Historical baseline
Range
High:$2.35B
Low:$42.83M
CAGR
+4.4%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $858.98M | -24.3% |
| 2023 | $1.13B | +2549.5% |
| 2022 | $42.83M | -93.1% |
| 2021 | $619.73M | -36.4% |
| 2020 | $975.04M | -58.5% |
| 2019 | $2.35B | +70.5% |
| 2018 | $1.38B | +13.9% |
| 2017 | $1.21B | +113.8% |
| 2016 | $565.91M | -2.7% |
| 2015 | $581.43M | - |